These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 17638895)

  • 1. Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer.
    Vignjevic D; Schoumacher M; Gavert N; Janssen KP; Jih G; Laé M; Louvard D; Ben-Ze'ev A; Robine S
    Cancer Res; 2007 Jul; 67(14):6844-53. PubMed ID: 17638895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer.
    Stein U; Arlt F; Walther W; Smith J; Waldman T; Harris ED; Mertins SD; Heizmann CW; Allard D; Birchmeier W; Schlag PM; Shoemaker RH
    Gastroenterology; 2006 Nov; 131(5):1486-500. PubMed ID: 17101323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel anti-invasive properties of a Fascin1 inhibitor on colorectal cancer cells.
    Montoro-García S; Alburquerque-González B; Bernabé-García Á; Bernabé-García M; Rodrigues PC; den-Haan H; Luque I; Nicolás FJ; Pérez-Sánchez H; Cayuela ML; Salo T; Conesa-Zamora P
    J Mol Med (Berl); 2020 Mar; 98(3):383-394. PubMed ID: 31996952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fascin1 expression in high-grade serous ovarian carcinoma is a prognostic marker and knockdown of fascin1 suppresses the proliferation of ovarian cancer cells.
    Park SH; Song JY; Kim YK; Heo JH; Kang H; Kim G; An HJ; Kim TH
    Int J Oncol; 2014 Mar; 44(3):637-46. PubMed ID: 24378809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of FOXN3 in colon cancer activates beta-catenin/TCF signaling and promotes the growth and migration of cancer cells.
    Dai Y; Wang M; Wu H; Xiao M; Liu H; Zhang D
    Oncotarget; 2017 Feb; 8(6):9783-9793. PubMed ID: 28039460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-catenin/Tcf-4 inhibition after progastrin targeting reduces growth and drives differentiation of intestinal tumors.
    Pannequin J; Delaunay N; Buchert M; Surrel F; Bourgaux JF; Ryan J; Boireau S; Coelho J; Pélegrin A; Singh P; Shulkes A; Yim M; Baldwin GS; Pignodel C; Lambeau G; Jay P; Joubert D; Hollande F
    Gastroenterology; 2007 Nov; 133(5):1554-68. PubMed ID: 17920061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3 increases gastric cancer cell motility by up-regulating fascin-1 expression.
    Kim SJ; Choi IJ; Cheong TC; Lee SJ; Lotan R; Park SH; Chun KH
    Gastroenterology; 2010 Mar; 138(3):1035-45.e1-2. PubMed ID: 19818782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axin downregulates TCF-4 transcription via beta-catenin, but not p53, and inhibits the proliferation and invasion of lung cancer cells.
    Yang LH; Xu HT; Han Y; Li QC; Liu Y; Zhao Y; Yang ZQ; Dong QZ; Miao Y; Dai SD; Wang EH
    Mol Cancer; 2010 Feb; 9():25. PubMed ID: 20122174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intervening in β-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis.
    Stein U; Arlt F; Smith J; Sack U; Herrmann P; Walther W; Lemm M; Fichtner I; Shoemaker RH; Schlag PM
    Neoplasia; 2011 Feb; 13(2):131-44. PubMed ID: 21403839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fascin1 suppresses RIG-I-like receptor signaling and interferon-β production by associating with IκB kinase ϵ (IKKϵ) in colon cancer.
    Matsumura T; Hida S; Kitazawa M; Fujii C; Kobayashi A; Takeoka M; Taniguchi SI; Miyagawa SI
    J Biol Chem; 2018 Apr; 293(17):6326-6336. PubMed ID: 29496994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-beta promotes invasion and metastasis of gastric cancer cells by increasing fascin1 expression via ERK and JNK signal pathways.
    Fu H; Hu Z; Wen J; Wang K; Liu Y
    Acta Biochim Biophys Sin (Shanghai); 2009 Aug; 41(8):648-56. PubMed ID: 19657566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periplocin from Cortex periplocae inhibits cell growth and down-regulates survivin and c-myc expression in colon cancer in vitro and in vivo via beta-catenin/TCF signaling.
    Zhao L; Shan B; Du Y; Wang M; Liu L; Ren FZ
    Oncol Rep; 2010 Aug; 24(2):375-83. PubMed ID: 20596624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In colon cancer cells fascin1 regulates adherens junction remodeling.
    Esmaeilniakooshkghazi A; Pham E; George SP; Ahrorov A; Villagomez FR; Byington M; Mukhopadhyay S; Patnaik S; Conrad JC; Naik M; Ravi S; Tebbutt N; Mooi J; Reehorst CM; Mariadason JM; Khurana S
    FASEB J; 2023 Mar; 37(3):e22786. PubMed ID: 36786724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor/Lef signaling.
    Deng YZ; Chen PP; Wang Y; Yin D; Koeffler HP; Li B; Tong XJ; Xie D
    J Biol Chem; 2007 Dec; 282(50):36571-81. PubMed ID: 17951630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of LRP1B in colon cancer promoted the growth and migration of cancer cells.
    Wang Z; Sun P; Gao C; Chen J; Li J; Chen Z; Xu M; Shao J; Zhang Y; Xie J
    Exp Cell Res; 2017 Aug; 357(1):1-8. PubMed ID: 28408316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New role of the antidepressant imipramine as a Fascin1 inhibitor in colorectal cancer cells.
    Alburquerque-González B; Bernabé-García M; Montoro-García S; Bernabé-García Á; Rodrigues PC; Ruiz Sanz J; López-Calderón FF; Luque I; Nicolas FJ; Cayuela ML; Salo T; Pérez-Sánchez H; Conesa-Zamora P
    Exp Mol Med; 2020 Feb; 52(2):281-292. PubMed ID: 32080340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NDRG2 expression decreases with tumor stages and regulates TCF/beta-catenin signaling in human colon carcinoma.
    Kim YJ; Yoon SY; Kim JT; Song EY; Lee HG; Son HJ; Kim SY; Cho D; Choi I; Kim JH; Kim JW
    Carcinogenesis; 2009 Apr; 30(4):598-605. PubMed ID: 19237607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
    Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
    Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YEATS4 promotes the tumorigenesis of pancreatic cancer by activating beta-catenin/TCF signaling.
    Jixiang C; Shengchun D; Jianguo Q; Zhengfa M; Xin F; Xuqing W; Jianxin Z; Lei C
    Oncotarget; 2017 Apr; 8(15):25200-25210. PubMed ID: 28445953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.